Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines
American biotech firm Moderna has released early results from its phase 3 clinical trials, announcing in a press release on
Read more
American biotech firm Moderna has released early results from its phase 3 clinical trials, announcing in a press release on
Read more